Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07310472

Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility

The goal of this intervention study is to learn if giving children influenza vaccinations in early childhood education facilities (i.e., daycare) will increase vaccination coverage compared to giving vaccinations only at healthcare. The main question it aims to answer is:

• Does offering children nasal influenza vaccine in daycare result in higher proportion of children getting influenza vaccine.

Researchers will compare daycare setting and healthcare setting as the location of giving influenza vaccines to children to see if more children will get vaccinated if they have an opportunity to receive nasal influenza vaccine at daycare.

Participants in the intervention group will:

• Have the opportunity to receive influenza vaccine in the daycare or in the healthcare

Participants in the comparison group will:

• Have the opportunity to receive influenza vaccine in the healthcare only

Recruiting

Interested in participating?

Request Info

Key information

Age range

2 year–6 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Turku

Turku, 20014, Finland

Location status: Recruiting

Location contact

Ville Peltola, MD, PhD

CONTACT

[email protected]

+35823132415

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Attending early childhood education (daycare) in the city of Turku

Exclusion criteria

  • No exclusion criteria

Treatment and study plan

Possibility to get live attenuated nasal influenza vaccine at daycare

Behavioral

The intervention is the possibility to get influenza vaccine in the daycare, in comparison to routine practice of getting influenza vaccine in a healthcare setting.

Primary outcomes

  1. Influenza vaccination coverage

    Time frame: From enrollment to the end of seasonal influenza vaccinations about 3 to 10 weeks later.

    Study child receiving any influenza vaccine

Study contacts

Contact information is provided by the study sponsor or research team.

Ville Peltola, MD, PhD

CONTACT

[email protected]

+35823132415

Sponsors and collaborators

Lead sponsor

Turku University Hospital

Other Gov

Collaborators

  • University of Turku

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 30, 2025
Registry last updated
Jan 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.